Baseline Assessment of SGLT2 Inhibitor Underuse in Outpatient CKD Clinics: A Quality Improvement Initiative
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026qa683bjb ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Ihtesham Shafiq und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Shafiq, I., Jan, M. U., Shah, S. M. O. M., Gyamlani, G. G., Naseer, A., & Hussein, W. F. (2026). Baseline Assessment of SGLT2 Inhibitor Underuse in Outpatient CKD Clinics: A Quality Improvement Initiative. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026qa683bjb
Vancouver
Shafiq I, Jan MU, Shah SMOM, Gyamlani GG, Naseer A, Hussein WF. Baseline Assessment of SGLT2 Inhibitor Underuse in Outpatient CKD Clinics: A Quality Improvement Initiative. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026qa683bjb
BibTeX
@article{Shafiq2026,
author = {Shafiq, Ihtesham and Jan, Muneeb Ullah and Shah, Syed Muhammad Obaida M. and Gyamlani, Geeta G. and Naseer, Adnan and Hussein, Wael F.},
title = {Baseline Assessment of SGLT2 Inhibitor Underuse in Outpatient CKD Clinics: A Quality Improvement Initiative},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026qa683bjb}
}
EUVIMED